ERBB2 and breast cancer: In NeuT mice an IL-12-adjuvanted allogeneic HER2/neu-expressing cell vaccine, repeatedly administered, was found to delay mammary cancer onset, leading to a more than doubled mice lifetime expectancy [2, 3].